Blydt-Hansen I, Bech M, Jackson S. Emicizumab in Severe Hemophilia A: Clinical and Patient Determinants of Transition Within a Standardized Program. J Hematol [Internet]. 2025 Oct. 30 [cited 2025 Nov. 4];14(5):257-61. Available from: https://jh.elmerpub.com/jh/article/view/2113